Phenylephrine does not improve oxygenation during one-lung ventilation: A randomized, double-blind, cross-over study

Area of Science:

• Anesthesiology
• Cardiovascular Physiology
• Pulmonary Medicine

Background:

• Phenylephrine, an alpha-1 adrenergic agonist, is hypothesized to enhance hypoxic pulmonary vasoconstriction (HPV).
• Clinical evidence supporting phenylephrine's augmentation of HPV is limited.
• This study investigated phenylephrine's effect on oxygenation during one-lung ventilation (OLV).

Purpose of the Study:

• To evaluate the clinical efficacy of phenylephrine infusion in improving oxygenation during OLV.
• To determine if phenylephrine augments HPV in patients undergoing thoracic surgery.
• To assess the hemodynamic effects of phenylephrine during OLV.

Main Methods:

• Prospective, randomized, double-blind, cross-over study design.
• Patients undergoing elective thoracic surgery with OLV were allocated to receive either normal saline or phenylephrine infusion first, followed by the alternative.
• Primary outcome was arterial partial pressure of oxygen; secondary outcomes included mean arterial pressure, heart rate, and pulse pressure variation.

Main Results:

• Phenylephrine infusion significantly increased mean arterial pressure but did not alter arterial partial pressure of oxygen.
• No significant carryover effect was observed for oxygenation.
• Phenylephrine significantly decreased heart rate and pulse pressure variation.

Conclusions:

• Phenylephrine infusion does not improve oxygenation during OLV in thoracic surgery patients.
• The findings suggest phenylephrine lacks clinically meaningful effects on HPV in this context.
• Further research may be needed to explore alternative strategies for managing oxygenation during OLV.